MEDICURE

Serial Number 76615137
Registration 3841797
800

Registration Progress

Application Filed
Oct 8, 2004
Under Examination
Jul 1, 2008
Approved for Publication
Mar 19, 2008
Published for Opposition
Apr 8, 2008
Registered
Aug 31, 2010

Basic Information

Serial Number
76615137
Registration Number
3841797
Filing Date
October 8, 2004
Registration Date
August 31, 2010
Published for Opposition
April 8, 2008
Renewal Date
August 31, 2020
Drawing Code
3000

Status Summary

Current Status
Active
Status Code
800
Status Date
Oct 1, 2020
Registration
Registered
Classes
005 042

Rights Holder

Medicure Inc.

03
Address
2-1250 Waverley Street
Winnipeg MANITOBA R3T 0P4
CA

Ownership History

Medicure Inc.

Original Applicant
03
Winnipeg MANITOBA R3T 0P4 CA

Medicure Inc.

Owner at Publication
03
Winnipeg MANITOBA R3T 0P4 CA

Medicure Inc.

Original Registrant
03
Winnipeg MANITOBA CA

Legal Representation

Attorney
Stacy J. Grossman

USPTO Deadlines

Next Deadline
1880 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2010-08-31)
Due Date
August 31, 2030
Grace Period Ends
February 28, 2031

Application History

50 events
Date Code Type Description
Oct 1, 2020 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 1, 2020 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Oct 1, 2020 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Oct 1, 2020 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Aug 20, 2020 E89R I TEAS SECTION 8 & 9 RECEIVED
Oct 29, 2019 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 29, 2019 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 31, 2019 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Nov 15, 2016 8.OK O REGISTERED - SEC. 8 (6-YR) ACCEPTED
Nov 15, 2016 NAS8 E NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Nov 8, 2016 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 31, 2016 ES8R I TEAS SECTION 8 RECEIVED
Aug 31, 2015 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 1, 2015 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 1, 2015 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 13, 2013 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 13, 2013 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 31, 2010 R.PR A REGISTERED-PRINCIPAL REGISTER
Jul 27, 2010 SUNA O NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
Jul 26, 2010 REGV O LAW OFFICE REGISTRATION REVIEW COMPLETED
Jul 25, 2010 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 28, 2010 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Jun 24, 2010 EISU I TEAS STATEMENT OF USE RECEIVED
Jun 24, 2010 IUAF S USE AMENDMENT FILED
Dec 14, 2009 EX3G S SOU EXTENSION 3 GRANTED
Dec 9, 2009 EEXT I SOU TEAS EXTENSION RECEIVED
Dec 9, 2009 EXT3 S SOU EXTENSION 3 FILED
Jul 21, 2009 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 21, 2009 EX2G S SOU EXTENSION 2 GRANTED
Jun 25, 2009 EEXT I SOU TEAS EXTENSION RECEIVED
Jun 25, 2009 EXT2 S SOU EXTENSION 2 FILED
Dec 24, 2008 EEXT I SOU TEAS EXTENSION RECEIVED
Dec 24, 2008 EXT1 S SOU EXTENSION 1 FILED
Dec 24, 2008 EX1G S SOU EXTENSION 1 GRANTED
Oct 17, 2008 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 1, 2008 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT
Apr 8, 2008 PUBO A PUBLISHED FOR OPPOSITION
Mar 19, 2008 NPUB O NOTICE OF PUBLICATION
Feb 29, 2008 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 28, 2008 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 9, 2008 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 9, 2008 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 8, 2008 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 17, 2007 CNSI R SUSPENSION INQUIRY WRITTEN
Dec 17, 2007 CNSI S INQUIRY AS TO SUSPENSION MAILED
Nov 29, 2007 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
May 29, 2007 ALIE A ASSIGNED TO LIE
May 29, 2007 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 24, 2006 CNSL R SUSPENSION LETTER WRITTEN
Nov 24, 2006 CNSL S LETTER OF SUSPENSION MAILED

Detailed Classifications

Class 005
Pharmaceutical preparations for use in the treatment of cardiovascular diseases
First Use Anywhere: Jun 4, 2010
First Use in Commerce: Jun 4, 2010
Class 042
Pharmaceutical research and development, including conducting clinical trials; providing information online relating to the research and development of pharmaceutical products for treating cardiovascular diseases
First Use Anywhere: Jun 4, 2010
First Use in Commerce: Jun 4, 2010

Additional Information

Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005 042